BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36800433)

  • 1. Cardiovascular Outcomes in Adults with Coronary Artery Disease and Obstructive Sleep Apnea with versus without Excessive Daytime Sleepiness in the RICCADSA Cinical Trial.
    Eulenburg C; Celik Y; Redline S; Thunström E; Glantz H; Strollo PJ; Peker Y
    Ann Am Thorac Soc; 2023 Jul; 20(7):1048-1056. PubMed ID: 36800433
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial.
    Peker Y; Glantz H; Eulenburg C; Wegscheider K; Herlitz J; Thunström E
    Am J Respir Crit Care Med; 2016 Sep; 194(5):613-20. PubMed ID: 26914592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous Positive Airway Pressure Treatment and Depression in Adults with Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea. A Secondary Analysis of the RICCADSA Trial.
    Balcan B; Thunström E; Strollo PJ; Peker Y
    Ann Am Thorac Soc; 2019 Jan; 16(1):62-70. PubMed ID: 30130421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CPAP and Health-Related Quality of Life in Adults With Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea in the RICCADSA Trial.
    Wallström S; Balcan B; Thunström E; Wolf A; Peker Y
    J Clin Sleep Med; 2019 Sep; 15(9):1311-1320. PubMed ID: 31538602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of continuous positive airway pressure therapy in coronary artery disease patients with nonsleepy obstructive sleep apnea.
    Luyster FS; Strollo PJ; Thunström E; Peker Y
    Clin Cardiol; 2017 Dec; 40(12):1297-1302. PubMed ID: 29243273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Benefit of Continuous Positive Airway Pressure in Adults with Coronary Artery Disease and Obstructive Sleep Apnea without Excessive Sleepiness.
    Azarbarzin A; Zinchuk A; Wellman A; Labarca G; Vena D; Gell L; Messineo L; White DP; Gottlieb DJ; Redline S; Peker Y; Sands SA
    Am J Respir Crit Care Med; 2022 Sep; 206(6):767-774. PubMed ID: 35579605
    [No Abstract]   [Full Text] [Related]  

  • 7. Obstructive sleep apnea and self-reported functional impairment in revascularized patients with coronary artery disease in the RICCADSA trial.
    Baniak LM; Chasens ER; Luyster FS; Strollo PJ; Thunström E; Peker Y
    Sleep Breath; 2018 Dec; 22(4):1169-1177. PubMed ID: 30324547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous positive airway pressure and adverse cardiovascular events in obstructive sleep apnea: are participants of randomized trials representative of sleep clinic patients?
    Reynor A; McArdle N; Shenoy B; Dhaliwal SS; Rea SC; Walsh J; Eastwood PR; Maddison K; Hillman DR; Ling I; Keenan BT; Maislin G; Magalang U; Pack AI; Mazzotti DR; Lee CH; Singh B
    Sleep; 2022 Apr; 45(4):. PubMed ID: 34739082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related impact of illness associated with excessive daytime sleepiness in patients with obstructive sleep apnea.
    Grandner MA; Min JS; Saad R; Leary EB; Eldemir L; Hyman D
    Postgrad Med; 2023 Jun; 135(5):501-510. PubMed ID: 37129416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Obstructive Sleep Apnea and CPAP Treatment on Cardiovascular Outcomes in Acute Coronary Syndrome in the RICCADSA Trial.
    Peker Y; Thunström E; Glantz H; Eulenburg C
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33333899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CPAP Does Not Reduce Inflammatory Biomarkers in Patients With Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea: A Randomized Controlled Trial.
    Thunström E; Glantz H; Yucel-Lindberg T; Lindberg K; Saygin M; Peker Y
    Sleep; 2017 Nov; 40(11):. PubMed ID: 29029237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous positive airway pressure treatment and anxiety in adults with coronary artery disease and nonsleepy obstructive sleep apnea in the RICCADSA trial.
    Celik Y; Thunström E; Strollo PJ; Peker Y
    Sleep Med; 2021 Jan; 77():96-103. PubMed ID: 33341644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world impact of continuous positive airway pressure on sleepiness in patients with obstructive sleep apnea in a national registry.
    Jennum P; Kjellberg J; Carls G; Ibsen R; Mettam S
    Sleep Med; 2024 Jun; 118():93-100. PubMed ID: 38657350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitolisant for Residual Excessive Daytime Sleepiness in OSA Patients Adhering to CPAP: A Randomized Trial.
    Pépin JL; Georgiev O; Tiholov R; Attali V; Verbraecken J; Buyse B; Partinen M; Fietze I; Belev G; Dokic D; Tamisier R; Lévy P; Lecomte I; Lecomte JM; Schwartz JC; Dauvilliers Y;
    Chest; 2021 Apr; 159(4):1598-1609. PubMed ID: 33121980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological Traits and Adherence to Sleep Apnea Therapy in Individuals with Coronary Artery Disease.
    Zinchuk AV; Chu JH; Liang J; Celik Y; Op de Beeck S; Redeker NS; Wellman A; Yaggi HK; Peker Y; Sands SA
    Am J Respir Crit Care Med; 2021 Sep; 204(6):703-712. PubMed ID: 34156917
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of CPAP treatment on leptin and adiponectin in adults with coronary artery disease and nonsleepy obstructive sleep apnoea in the RICCADSA trial.
    Balcan B; Thunström E; Yucel-Lindberg T; Lindberg K; Ay P; Peker Y
    Sleep Med; 2020 Mar; 67():7-14. PubMed ID: 31884309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Inverse-Probability-of-Treatment Weighting to Estimate the Effect of Daytime Sleepiness in Patients with Obstructive Sleep Apnea.
    Bettega F; Leyrat C; Tamisier R; Mendelson M; Grillet Y; Sapène M; Bonsignore MR; Pépin JL; Kattan MW; Bailly S
    Ann Am Thorac Soc; 2022 Sep; 19(9):1570-1580. PubMed ID: 35380937
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of CPAP on diastolic function in coronary artery disease patients with nonsleepy obstructive sleep apnea: A randomized controlled trial.
    Glantz H; Johansson MC; Thunström E; Guron CW; Uzel H; Saygin M; Herlitz J; Peker Y
    Int J Cardiol; 2017 Aug; 241():12-18. PubMed ID: 28408103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epworth Sleepiness Scale may be an indicator for blood pressure profile and prevalence of coronary artery disease and cerebrovascular disease in patients with obstructive sleep apnea.
    Feng J; He QY; Zhang XL; Chen BY;
    Sleep Breath; 2012 Mar; 16(1):31-40. PubMed ID: 21243439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CPAP Intervention as an Add-On Treatment to Lipid-Lowering Medication in Coronary Artery Disease Patients with Obstructive Sleep Apnea in the RICCADSA Trial.
    Celik Y; Balcan B; Peker Y
    J Clin Med; 2022 Jan; 11(1):. PubMed ID: 35012012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.